Titre:
  • Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin.
Auteur:Boothman, Isabelle; Clayton, Lisa M S; McCormack, Mark; Driscoll, Alexandra McKibben; Stevelink, Remi; Moloney, Patrick; Krause, Roland; Kunz, Wolfram W.S.; Diehl, Sarah; O'Brien, Terence; Sills, Graeme; de Haan, Gerrit Jan; Zara, Federico; Koeleman, B.P.C.; Depondt, Chantal; Marson, Anthony Guy; Stefansson, Hreinn; Stefansson, Kari; Craig, John; Johnson, Michael R; Striano, Pasquale; Lerche, Holger; Furney, Simon; Delanty, Norman; Consortium EpiPGX, Sanjay M; Sisodiya, Gianpiero L; Cavalleri,
Informations sur la publication:Frontiers in Neuroscience, 17, page (1156362)
Statut de publication:Publié, 2023-11-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:adverse drug reaction
epilepsy
genome wide association study
polygenic risk score
retina
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1662-453X
info:doi/10.3389/fnins.2023.1156362
info:scp/85173599266
info:pmid/37790589
PMC10542409